Louise Gagnoneditorial@labpulse.comDiagnostic TechnologiesCOVID-19 testing offers chance for diabetes screening, tooStudy investigators hypothesized that they could leverage the existing COVID-19 testing infrastructure to also test for prediabetes and diabetes in a Latinx community that might otherwise face substantial barriers to care engagement.May 26, 2022Stomach CancerDr. Elizabeth Stern: A pioneer in cytopathology screeningEarly yearsMarch 28, 2022Sickle Cell AnemiaHalf of world lacks access to diagnostic testingThe objective of the report was to quantify the state of diagnostics across the globe, according to Susan Horton, one of the members of the Lancet Commission on diagnostics who contributed to the preparation of the report and a professor of global health economics at the University of Waterloo in Canada.October 11, 2021Page 1 of 1Top StoriesCancerInvivoscribe, Complete Genomics partner to develop NGS tests for cancer research, detectionUnder the terms of the deal, Invivoscribe will be responsible for the development of biomarker tests, including test controls and associated bioinformatics software. The tests will run on Complete Genomics' NGS platforms.Regulatory ApprovalSeegene obtains IVDR certification for 30 diagnostic assaysPolicy and RegulationAdvocacy groups in letter urge FDA to develop regulations for lab-developed testsCollaborationNucleai, Adlai Nortye collaborate on biomarkers for clinical trialsSponsor ContentVisit our Molecular Diagnostics Community